 |
17 Diseases |  |
0 Trials |
|
0 Trials |  |
2 News |  |
- |||| Locteron (interferon alpha-2b CR) / Biolex
Trial completion, P2b data: 480S: 480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV) (clinicaltrials.gov) - Jan 31, 2012
P2, N=74, Completed, Sponsor: Biolex Therapeutics, Inc.
Active, not recruiting --> Completed
- |||| Locteron (interferon alpha-2b CR) / Biolex
Trial completion: SELECT-2: Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV (clinicaltrials.gov) - Jan 31, 2012
P2b, N=116, Completed, Sponsor: Biolex Therapeutics, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed